JPS5480405A - High calorie solution of low molecular weight glucose polymer mixture being useful for intravenous dose - Google Patents

High calorie solution of low molecular weight glucose polymer mixture being useful for intravenous dose

Info

Publication number
JPS5480405A
JPS5480405A JP13634678A JP13634678A JPS5480405A JP S5480405 A JPS5480405 A JP S5480405A JP 13634678 A JP13634678 A JP 13634678A JP 13634678 A JP13634678 A JP 13634678A JP S5480405 A JPS5480405 A JP S5480405A
Authority
JP
Japan
Prior art keywords
useful
molecular weight
low molecular
polymer mixture
intravenous dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13634678A
Other languages
English (en)
Inventor
Baarou Ramuzei Anii
Sadeyuusu Gazetsuku Debitsudo
Rotsuteman Robaato
Aaru Riyuuku Derubaato
Hatsushi Chiaarangu
Dei Reazemu Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JPS5480405A publication Critical patent/JPS5480405A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C13—SUGAR INDUSTRY
    • C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K1/00—Glucose; Glucose-containing syrups
    • C13K1/06—Glucose; Glucose-containing syrups obtained by saccharification of starch or raw materials containing starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP13634678A 1977-11-21 1978-11-07 High calorie solution of low molecular weight glucose polymer mixture being useful for intravenous dose Pending JPS5480405A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/853,366 US4182756A (en) 1977-11-21 1977-11-21 High calorie solutions of low molecular weight glucose polymer mixtures useful for intravenous administration

Publications (1)

Publication Number Publication Date
JPS5480405A true JPS5480405A (en) 1979-06-27

Family

ID=25315837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13634678A Pending JPS5480405A (en) 1977-11-21 1978-11-07 High calorie solution of low molecular weight glucose polymer mixture being useful for intravenous dose

Country Status (7)

Country Link
US (1) US4182756A (ja)
JP (1) JPS5480405A (ja)
AU (1) AU518747B2 (ja)
CA (1) CA1099639A (ja)
DE (1) DE2850247A1 (ja)
GB (1) GB2008406B (ja)
PH (1) PH14449A (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003329A1 (en) * 1981-03-31 1982-10-14 David B A Silk Glucose polymers and method of producing same
US4761237A (en) * 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
EP0083360B1 (en) * 1981-07-10 1987-04-15 Baxter Travenol Laboratories, Inc. Peritoneal dialyses solution containing carbohydrate polymers
US4879280A (en) * 1981-09-24 1989-11-07 Fresenius Ag Dialysis solution for use in intraperitoneal dialysis
EP0076355A3 (en) * 1981-10-01 1983-05-25 Abbott Laboratories Improved peritoneal dialysis solution
US4542123A (en) * 1982-01-11 1985-09-17 Massachusetts Institute Of Technology Composition and method for increasing brain tyrosine levels
JPS5916818A (ja) * 1982-07-20 1984-01-28 Shimizu Seiyaku Kk 経静脈投与用輸液剤
GB8300718D0 (en) 1983-01-12 1983-02-16 Milner Research Ireland Ltd Glucose polymer solutions
JPS59170017A (ja) * 1983-03-18 1984-09-26 Sapporo Breweries Ltd 新規多糖体ｒｄｐ物質，その製造法およびそれを有効成分とする抗腫瘍剤、免疫調節剤および感染症予防治療剤
US4572907A (en) * 1984-03-22 1986-02-25 Abbott Laboratories High caloric product for I.V. administration
US6248726B1 (en) * 1985-06-22 2001-06-19 M L Laboratories Plc Method of peritoneal dialysis using glucose polymer solutions
US20040062802A1 (en) * 1998-04-02 2004-04-01 Hermelin Victor M. Maximizing effectiveness of substances used to improve health and well being
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
DE10217356B4 (de) 2002-04-18 2012-03-29 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
WO2009049160A1 (en) 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Methods of treating gastrointestinal disorders independent of the intake of food
EP2288714A4 (en) 2008-05-09 2014-12-03 Cargill Inc REDUCED SUGAR LEVEL VISCOSITY SYRUP, METHODS OF MAKING SAME, AND APPLICATIONS THEREOF
US9730464B2 (en) 2008-05-09 2017-08-15 Cargill, Incorporated Carbohydrate compositions
FR2945043B1 (fr) * 2009-04-30 2019-07-26 Roquette Freres Procede de purification de polymeres de glucose destines aux solutions de dialyse peritoneale
GB2499463B (en) 2012-01-31 2014-04-02 Verenium Corp Reduced sugar syrups and methods of making reduced sugar syrups
CA2906984A1 (en) 2013-03-15 2014-09-18 Cargill, Incorporated Carbohydrate compositions
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3381484A1 (en) 2017-03-31 2018-10-03 Opterion Health AG Carbohydrate composition for dialysis
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444901A (en) * 1972-05-02 1976-08-04 Milner Scient Medical Research Glucose polymers
US4021543A (en) * 1975-03-28 1977-05-03 Abbott Laboratories Process for disguising saline taste of pharmaceuticals and product thereof

Also Published As

Publication number Publication date
GB2008406B (en) 1982-07-14
PH14449A (en) 1981-07-23
AU518747B2 (en) 1981-10-15
US4182756A (en) 1980-01-08
DE2850247A1 (de) 1979-05-23
GB2008406A (en) 1979-06-06
CA1099639A (en) 1981-04-21

Similar Documents

Publication Publication Date Title
JPS5480405A (en) High calorie solution of low molecular weight glucose polymer mixture being useful for intravenous dose
AU4125078A (en) High calorie solutions of low molecular weight glucose polymer mixtures
GB2035093B (en) Medical articles made of blood compatible polymers
GB2014953B (en) Intravenous administration set
AU4690379A (en) Administering intravenous drugs
JPS5455625A (en) Low molecular weight meso phase pitch
AU2841077A (en) Preparation of low molecular weight polhydroxyl compounds
AU512448B2 (en) The use of cyclic carbonic acid esters as solvents for poly-(b-hydroxy butric acid
AU1143776A (en) Parenteral liquid administration set
AU1810176A (en) Prefilled two compartment syringe
JPS5446288A (en) Preparation of low molecular weight polyhydroxyl compound
DE2861610D1 (en) Process for preparing low molecular weight polyhydroxylic compounds and their use for the preparation of polyurethanes
JPS5427536A (en) Compound having mean molecular weight of 300012000 containing at least one hydroxyl group and at least one urethanoarylsulfonate group and process for preparing same
FR2390454A1 (fr) 17-alkylthio (et arylthio)-1', 2', 3', 4'-tetrahydroandrosteno(16 a, 17 a-b)naphtalenes et derives, et leur utilisation comme medicaments
GB2014952B (en) Metering apparatus especially for use with an intravenous solution administration set
JPS5419983A (en) Enol group containing compound * organic substance containing same and high molecular weight compound comprising said compound as structure unit
EP0412899A3 (en) Oxazolo pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
JPS5470400A (en) Preparation of phosphazene polymer
JPS5478788A (en) Preparation of polymer of forming grade
JPS53115798A (en) Manufacture of high molecular weight linear elastomer of thiodiethanol
JPS52134689A (en) Process for combining polymer carrier with ligand of high and low molecular weight
IL55152A (en) 7-acylamido-3-cephem-4-carboxylic acid compounds with terminal alpha-aminocarboxylic acid groups,their preparation and pharmaceutical compositions containing them
JPS5276363A (en) Stabilization of crossslinkable polymer
JPS53133292A (en) Process for producing salt of hydroxycarboxylated polymer with reduced molecular weight
PH16347A (en) Improved nitroglycerin infusion set for the intravenous administration of nitroglycerin solution